April 19, 2017
GlaxoSmithKline PLC said on April 18 that Japan Vaccine, its joint venture with Daiichi Sankyo, has filed a new drug application in Japan for the candidate shingles vaccine, Shingrix, for the prevention of herpes zoster, or shingles, in people aged...read more